Web Sify
Follow us on
Sify.com » Topics » Pharma
Pharma News

Ventrus rises on trial of anal fissure treatment
Shares of Ventrus Biosciences Inc. jumped Monday after the company said a late-stage study shows its diltiazem cream is more effective than a placebo as a treatment for anal fissures.The cream is designed to treat pain caused by anal fissures, which are tears in the lining of the anal canal. Those tears can cause severe pain. Ventrus said two strengths of diltiazem were more effective than a placebo